Latest Combination drugs Stories
NEW YORK, April 15, 2015 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased Orexigen Therapeutics, Inc.
SAN DIEGO, March 30, 2015 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced that Tom Cannell has joined as Chief Commercial Officer.
LONDON, March 24, 2015 /PRNewswire/ -- Key Findings--Chronic obstructive pulmonary disorder (COPD) is the third leading cause of death in the United States, and is in fourth
NEW YORK, March 6, 2015 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Orexigen
Physicians declare first week of Spring as Medicine Cabinet Clean-up Week HARRISBURG, Pa., March 2, 2015 /PRNewswire-USNewswire/ -- After marijuana and alcohol, the most commonly abused
Fifteen Accepted Abstracts Include New Data From: NORTH CHICAGO, Ill., Feb.
- Contrave® net sales total $6.5 million in first 10 weeks of launch SAN DIEGO, Feb. 25, 2015 /PRNewswire/ -- Orexigen Therapeutics, Inc.
- Decision could speed access to LCZ696 for heart failure with reduced ejection fraction patients in the US, reducing total review time from 12 to 8 months(1) EAST HANOVER, N.J., Feb.
SAN DIEGO, Feb. 9, 2015 /PRNewswire/ -- Orexigen Therapeutics, Inc.
- The act of burning, scorching, or heating to dryness; the state or being thus heated or dried.
- In medicine, cauterization.